Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesDividends payablesLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Pharma-Bio Serv (PBSV) Capital Leases (2016 - 2021)

Pharma-Bio Serv (PBSV) has disclosed Capital Leases for 11 consecutive years, with $52430.0 as the latest value for Q1 2021.

  • For the quarter ending Q1 2021, Capital Leases fell 18.37% year-over-year to $52430.0, compared with a TTM value of $52430.0 through Jan 2021, down 18.37%, and an annual FY2020 reading of $55439.0, down 17.35% over the prior year.
  • Capital Leases was $52430.0 for Q1 2021 at Pharma-Bio Serv, down from $55439.0 in the prior quarter.
  • Across five years, Capital Leases topped out at $72668.0 in Q2 2019 and bottomed at $20206.0 in Q2 2017.
  • Average Capital Leases over 5 years is $53923.1, with a median of $56397.0 recorded in 2018.
  • The sharpest move saw Capital Leases skyrocketed 162.12% in 2018, then decreased 24.61% in 2019.
  • Year by year, Capital Leases stood at $59795.0 in 2017, then fell by 23.03% to $46027.0 in 2018, then surged by 45.74% to $67079.0 in 2019, then dropped by 17.35% to $55439.0 in 2020, then decreased by 5.43% to $52430.0 in 2021.
  • Business Quant data shows Capital Leases for PBSV at $52430.0 in Q1 2021, $55439.0 in Q4 2020, and $58408.0 in Q3 2020.